{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:02:25Z","timestamp":1787749345830,"version":"build-2784847793"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Myasthenia gravis (MG) is a heterogeneous autoimmune disorder characterized by neuromuscular transmission failure and skeletal muscle fatigability, with a pathophysiology involving both cellular and humoral immune components. Despite growing interest in the immunological etiology of MG, few functional studies have addressed the role of T cells, and most existing work has focused on quantifying immune cell subsets using flow cytometry. In this study, a comparative\n                    <jats:italic>in vitro<\/jats:italic>\n                    analysis of resting and activated CD4+ and CD8+ T cells from MG patients and healthy controls (HC) was performed using the multiplex Proximity Extension Assay (PEA) proteomics to assess the secretion of inflammatory proteins, including cytokines and chemokines, and to define the inflammatory status of T cells in MG. Data analysis was performed using the Boruta algorithm to detect both linear and non-linear patterns, followed by multiple testing corrections, and correlation analyses. The results revealed distinct alterations in the secretion profiles of several inflammatory proteins in MG compared to HC across both T cell subsets, regardless of activation state. Notably, resting CD4+ T cells from MG patients secreted higher levels of VEGFA, TNFRSF9, TWEAK, CCL20, HGF, CCL19, TRAIL, IL18, and TNF-\u03b2 whereas resting CD8+ T cells secreted higher levels of IL-12B, TRAIL, CCL23, CD244, CXCL11, CCL20, VEGFA, PD-L1, and OSM relative to HC. In contrast, activated CD4+ and CD8+ cells from MG patients exhibited a blunted secretion profile compared to HC, suggesting functional exhaustion. Furthermore, MG-ADL scores correlated with the secretion levels of 14 proteins from resting CD4+ cells, including seven cytokines, five chemokines, and two matrix metalloproteins. Some of the CD4+ T cell secreted proteins also correlated with their corresponding serum or plasma levels\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Overall, these findings indicate that T cells in MG exhibit a skewed inflammatory profile characterized by heightened basal activation and impaired inducibility, suggestive of an exhausted phenotype. The interplay between these altered T cell functions and aberrant B cell responses in MG warrants further investigation and may provide novel insights into disease immunopathophysiology as well as opportunities for targeted immunomodulatory therapies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1648020","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T05:26:20Z","timestamp":1754285180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling"],"prefix":"10.3389","volume":"16","author":[{"given":"Amol K.","family":"Bhandage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.104468","article-title":"275th ENMC international workshop: Seronegative myasthenia gravis: An update paradigm for diagnosis and management, 9\u201311 February 2024, Hoofddorp, the Netherlands","volume":"44","author":"Evoli","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor\u2013positive myasthenia gravis patients","volume-title":"Annals of the new york academy of sciences","author":"Villegas","year":"2018"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00782","article-title":"Comparative analysis of thymic and blood treg in myasthenia gravis: thymic epithelial cells contribute to thymic immunoregulatory defects","volume":"11","author":"Truffault","year":"2020","journal-title":"Front Immunol"},{"key":"B5","article-title":"Blood and digital biomarkers in MG","volume-title":"International review of neurobiology","author":"Bhandage","year":"2025"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1083218","article-title":"Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells","volume":"14","author":"Verdier","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(21)00463-4","article-title":"Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders","volume":"21","author":"Verschuuren","year":"2022","journal-title":"Lancet Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00028-0","article-title":"Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study","volume":"23","author":"Narayanaswami","year":"2024","journal-title":"Lancet Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01726-y","article-title":"Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals","volume":"82","author":"Menon","year":"2022","journal-title":"Drugs"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4+ T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS","volume":"11","author":"\u00c7ebi","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/22143602251348753","article-title":"On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales","volume":"12","author":"Bhandage","year":"2025","journal-title":"J Neuromuscular Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2024.110564","article-title":"Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls","volume":"27","author":"Bhandage","year":"2024","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.03.019","article-title":"GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4(+) T cells and is immunosuppressive in type 1 diabetes","volume":"30","author":"Bhandage","year":"2018","journal-title":"EBioMedicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01688","article-title":"Editorial: advances in autoimmune myasthenia gravis","volume-title":"Frontiers in immunology","author":"Punga","year":"2020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1134\/S0006297916050060","article-title":"Role of vascular endothelial growth factor (VEGF) in thymus of mice under normal conditions and with tumor growth","volume":"81","author":"Kisseleva","year":"2016","journal-title":"Biochem (Mosc)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1736-20.2020","article-title":"Macrophage-derived vascular endothelial growth factor-A is integral to neuromuscular junction reinnervation after nerve injury","volume":"40","author":"Lu","year":"2020","journal-title":"J Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The TNF receptor superfamily in co-stimulating and co-inhibitory responses","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1838141","article-title":"Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response","volume":"9","author":"Li","year":"2020","journal-title":"Oncoimmunology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1038\/s41467-021-27613-w","article-title":"CD137 (4-1BB) costimulation of CD8(+) T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation","volume":"12","author":"Otano","year":"2021","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1189\/jlb.72.1.35","article-title":"CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers","volume":"72","author":"Pauly","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200909117","article-title":"The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice","volume":"188","author":"Mittal","year":"2010","journal-title":"J Cell Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.ATV.0000062883.93715.37","article-title":"TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity","volume":"23","author":"Donohue","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.12.018","article-title":"CCR6 as a mediator of immunity in the lung and gut","volume":"317","author":"Ito","year":"2011","journal-title":"Exp Cell Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scandinavian J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-918","article-title":"Glucose metabolism pattern of peripheral blood immune cells in myasthenia gravis patients","volume":"8","author":"Li","year":"2020","journal-title":"Ann Trans Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.10.012","article-title":"Imbalance of the two main circulating dendritic cell subsets in patients with myasthenia gravis","volume":"205","author":"Chen","year":"2019","journal-title":"Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000529626","article-title":"Aberrant dendritic cell subsets in patients with myasthenia gravis and related clinical features","volume":"30","author":"Song","year":"2023","journal-title":"NeuroImmunoModulation"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101469","article-title":"The role of TRAIL\/DRs in the modulation of immune cells and responses","volume":"11","author":"Sag","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020405","article-title":"Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)\/fibroblast growth factor-inducible 14 (Fn14) axis in cardiovascular diseases: progress and challenges","volume":"9","author":"Mendez-Barbero","year":"2020","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156708","article-title":"T cells exhaustion, inflammatory and cellular activity markers in PBMCs predict treatment outcome in pulmonary tuberculosis patients","volume":"182","author":"Nii Otinkorang Ankrah","year":"2024","journal-title":"Cytokine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02809","article-title":"The emerging role of CD244 signaling in immune cells of the tumor microenvironment","volume":"9","author":"Agresta","year":"2018","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134533","article-title":"Regulation of CNS precursor function by neuronal chemokines","volume":"715","author":"Watson","year":"2020","journal-title":"Neurosci Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2006.11.002","article-title":"IL-12p40: an inherently agonistic cytokine","volume":"28","author":"Cooper","year":"2007","journal-title":"Trends Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt034","article-title":"Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis","volume":"22","author":"Johnston","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.05.028","article-title":"Characterisation of soluble murine CD137 and its association with systemic lupus","volume":"45","author":"Shao","year":"2008","journal-title":"Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.10.012","article-title":"Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis","volume":"27","author":"Kanatli","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.5812\/archneurosci.63360","article-title":"Association of interleukin-12B gene polymorphism with multiple sclerosis in patients from southeast of Iran","volume":"5","author":"Nemati","year":"2018","journal-title":"Arch Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13760-018-0994-9","article-title":"Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis","volume":"118","author":"Benesov\u00e1","year":"2018","journal-title":"Acta Neurologica Belgica"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1904319116","article-title":"Caspase-8 restricts antiviral CD8 T cell hyperaccumulation","volume":"116","author":"Feng","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1063703","article-title":"Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity","volume":"17","author":"Salmena","year":"2003","journal-title":"Genes Dev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12967-023-04421-y","article-title":"Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics","volume":"21","author":"Zhong","year":"2023","journal-title":"J Transl Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109177","article-title":"Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities","volume":"245","author":"Alahdal","year":"2022","journal-title":"Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0074-7742(07)79003-7","article-title":"The role of CD4 T cells in the pathogenesis of multiple sclerosis","volume":"79","author":"Chitnis","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T cells in multiple sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T05:26:21Z","timestamp":1754285181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2025.1648020"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1648020","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"article-number":"1648020"}}